Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085
Published July 13, 2022 · Recall initiated: June 10, 2022
Summary
FDA records drug Class II recall D-1182-2022, published July 13, 2022 and initiated June 10, 2022. Recalling firm: Wedgewood Village Pharmacy, LLC; Status: Terminated; Reported quantity: 24 bottles; Lot: Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Wedgewood Village Pharmacy, LLC
- Distributor
- Products were distributed nationwide in the USA.
- Lot
- Lot#: 000-03852523, Exp Date: 09/01/22; Lot#: 000-03766625, Exp Date:07/10/22; Lot#: 000-03780127, Exp Date: 08/6/22; Lot#: 000-03794760, Exp Date: 08/6/22; Lot#: 000-03892723, Exp Date: 09/1/22; Lot#: 000-03641022, Exp Date: 06/17/22; Lot#: 000-03693714, Exp Date: 06/28/22; Lot#: 000-03770510, Exp Date: 08/6/22; Lot#: 000-03852462, Exp Date: 09/1/22; Lot#: 000-03840601, Exp Date: 09/1/22; Lot#: 000-03706934, Exp Date: 06/28/22; Lot#: 000-03850609, Exp Date: 09/1/22; Lot#: 000-03650269, Exp Date: 06/17/22; Lot#: 000-03870004, Exp Date: 09/1/22; Lot#: 000-03693748, Exp Date: 06/28/22; Lot#: 000-03904403, Exp Date: 09/1/22; Lot#: 000-03799564, Exp Date: 08/06/22; Lot#: 000-03723022, Exp Date: 06/28/22; Lot#: 000-03872892, Exp Date: 09/01/22; Lot#: 000-03885204, Exp Date: 09/01/22; Lot#: 000-03848586, Exp Date: 09/01/22; Lot#: 000-03903599, Exp Date: 09/01/22; Lot#: 000-03812001, Exp Date: 08/06/22;
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABethanechol Chloride 1mg/ml, 80 ml Suspension bottles Banana/Strawberry, Qty:1, Wedgewood Village PharmacyJuly 13, 2022
- FDAEstriol 1mg/gm, Vaginal Cream, 60 gm tube, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Drive, Ste 200,July 13, 2022
- FDABoric Acid 600 mg capsules, 14 capsules per box, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Drive, SteJuly 13, 2022
- FDABoric Acid 600 mg per suppository, 14 Vaginal Suppositories per box, Wedgewood Village Pharmacy LLC, 405 HeronJuly 13, 2022
- FDAEnalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro PharmaceuticalJuly 13, 2022
- FDAEnalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro PharmaceuticalJuly 13, 2022
Questions about this recall
Was Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085 recalled?
Yes. FDA published recall D-1182-2022 on July 13, 2022. Reported hazard: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
What should I do if I have this product?
Voluntary: Firm initiated